CAS
IDXX icon

Coppell Advisory Solutions’s Idexx Laboratories IDXX Stock Holding History

Coppell Advisory Solutions’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13
Closed -$5.37K – 1045
2024
Q4 		$5.37K Buy
13
+7
+117% +$3.07K ﹤0.01% 1305
2024
Q3 		$3.07K Hold
6
– – ﹤0.01% 1364
2024
Q2 		$2.92K Buy
+6
New +$3.01K ﹤0.01% 1312
2023
Q4 		$3.88K Buy
+7
New +$3.29K ﹤0.01% 1164

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Coppell Advisory Solutions's IDXX Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 13 shares — an estimated $5.37K sold.

Coppell Advisory Solutions first reported a position in IDXX in Q4 2023 and held it in 4 quarters. The position peaked at $5.37K in Q4 2024. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 13 Idexx Laboratories shares in Q1 2025, an estimated $5.37K.
  • Coppell Advisory Solutions first reported a position in Idexx Laboratories in Q4 2023 and held it in 4 quarters.
  • Coppell Advisory Solutions's Idexx Laboratories position peaked at $5.37K in Q4 2024.
  • 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.